IMUX FY 2024 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena

IMUXImmunic, Inc.

$135M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$98M

Net Income

-$101M

EPS (Diluted)

$-1.00

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$85M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$41M

Total Liabilities

$22M

Stockholders' Equity

$18M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$98M	-$99M	+1.2%
Net Income	-$101M	-$94M	-7.4%